Quick Facts
  • pin location icon
    Primary Location:
    Allegheny General Hospital
  • wavy circle icon with check mark inside
    Esophageal Cancer
    Trachea Disorders
  • magnifying glass with heart icon
    Surgical Oncology
  • gender symbols interlocked icon
  • chat box with different language translations icon
  • certificate with a ribbon icon below
    Med School:
    Loyola Marymount University, Creighton University School of Medicine

Get to Know Dr. Blair Jobe

Dr. Blair Jobe is director of the Allegheny Health Network Esophageal and Lung Institute in Pittsburgh and a pioneer in the field of minimally invasive surgery.

Jobe is one of the country’s preeminent specialists in endoscopic therapy for the treatment of esophageal cancer. He also handles cases of malignant pleural mesothelioma.

As a prolific medical researcher, he has been the principal investigator for two large grants from the National Institutes of Health that focused on early detection of esophageal disease. The research includes the development of tissue and serum biomarkers.

Earlier in his career he was honored with a Health Care Heroes Award for his discovery of four protein biomarkers that later became an accurate and inexpensive way to determine whether esophageal cancer was present.

Contact Dr. Blair Jobe

Specialties of Dr. Blair Jobe

  • Esophageal cancer
  • Esophageal motility disorders
  • Dysplasia
  • Barrett’s esophagus
  • Achalasia
  • Tracheal disorders

Dr. Blair Jobe’s Experience and Medical Education

  • Allegheny Health Network
  • University of Pittsburgh Medical Center
  • American Board of Surgery
  • Creighton University School of Medicine (M.D.)
  • Oregon Health & Science University (Residency)
  • Swedish Medical Center, Seattle (Fellowship)

Awards and Other Recognitions

  • Health Care Heroes Award, Pittsburgh Business Times
  • Outstanding Researcher of the Year Award, Society of American Gastrointestinal and Endoscopic Surgeons

Publications of Dr. Blair Jobe

  • Babar, L. et al. (2019, July 16). Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma. Oncotarget.
  • Kelly, R.J. et al. (2018, December 26). The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation. Annals of Thoracic Surgery.
  • Komatsu, Y., Newhams, K.M. & Jobe, B.A. (2018, November 28). Enhancing the Detection of Barrett Esophagus. Thoracic Surgery Clinic.
  • Alicuben, E.T. et al. (2018, April 17). Worldwide Experience with Erosion of the Magnetic Sphincter Augmentation Device. Journal of Gastrointestinal Surgery.